Literature DB >> 15618547

Glucosamine-induced endoplasmic reticulum stress promotes ApoB100 degradation: evidence for Grp78-mediated targeting to proteasomal degradation.

Wei Qiu1, Rita Kohen-Avramoglu, Shailen Mhapsekar, Julie Tsai, Richard C Austin, Khosrow Adeli.   

Abstract

OBJECTIVE: To investigate the role of glucosamine-mediated endoplasmic reticulum (ER) stress and Grp78 (BiP) in the intracellular degradation of apolipoprotein B100 (apoB100) in cultured hepatocytes. METHODS AND
RESULTS: Glucosamine treatment (2.5 to 10 mmol/L) of HepG2 cells increased levels of the ER chaperones, 78-kDa glucose-regulated protein (Grp78) and Grp94, in a dose-dependent manner and led to significant decreases in both cellular and secreted apoB100 by up to 97% (P<0.01). In contrast, no changes were observed in ER resident (ER60, PTP-1B) or secretory (albumin, apoE) control proteins. Glucosamine-induced apoB degradation was similarly observed in primary hamster hepatocytes and McA-RH7777 cells. Glucosamine treatment led to reduced tranlocational efficiency of apoB100 in the ER and enhanced its ubiquitination and proteasomal degradation. Adenoviral overexpression of Grp78 also led to significantly decreased levels of newly synthesized apoB100 in a dose-dependent manner (P<0.01). Grp78-induced downregulation of apoB100 was sensitive to inhibition by the proteasome inhibitor, lactacystin, but not lysosomal protease inhibitors, E64 and leupeptin, suggesting that overexpression of Grp78 selectively induced proteasomal degradation of apoB100.
CONCLUSIONS: These findings suggest that binding and retention by Grp78 may play a critical role in proteasomal targeting and the ER quality-control of misfolded apoB. Interaction with core lipoprotein lipids may facilitate apoB transport out of the ER by reducing Grp78-mediated ER retention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15618547     DOI: 10.1161/01.ATV.0000154142.61859.94

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  30 in total

1.  FoxO1 links hepatic insulin action to endoplasmic reticulum stress.

Authors:  Adama Kamagate; Dae Hyun Kim; Ting Zhang; Sandra Slusher; Roberto Gramignoli; Stephen C Strom; Suzanne Bertera; Steven Ringquist; H Henry Dong
Journal:  Endocrinology       Date:  2010-05-25       Impact factor: 4.736

2.  Global mass spectrometry and transcriptomics array based drug profiling provides novel insight into glucosamine induced endoplasmic reticulum stress.

Authors:  Ana Sofia Carvalho; Helena Ribeiro; Paula Voabil; Deborah Penque; Ole N Jensen; Henrik Molina; Rune Matthiesen
Journal:  Mol Cell Proteomics       Date:  2014-08-15       Impact factor: 5.911

3.  Gene regulatory network of unfolded protein response genes in endoplasmic reticulum stress.

Authors:  Sayuri Takayanagi; Riga Fukuda; Yuuki Takeuchi; Sakiko Tsukada; Kenichi Yoshida
Journal:  Cell Stress Chaperones       Date:  2012-07-18       Impact factor: 3.667

Review 4.  Membrane Protein Quantity Control at the Endoplasmic Reticulum.

Authors:  Ignat Printsev; Daniel Curiel; Kermit L Carraway
Journal:  J Membr Biol       Date:  2016-10-14       Impact factor: 1.843

5.  The Hsp110 molecular chaperone stabilizes apolipoprotein B from endoplasmic reticulum-associated degradation (ERAD).

Authors:  Stacy L Hrizo; Viktoria Gusarova; David M Habiel; Jennifer L Goeckeler; Edward A Fisher; Jeffrey L Brodsky
Journal:  J Biol Chem       Date:  2007-09-06       Impact factor: 5.157

Review 6.  The ever-expanding role of degradation in the regulation of apolipoprotein B metabolism.

Authors:  Henry N Ginsberg; Edward A Fisher
Journal:  J Lipid Res       Date:  2008-12-02       Impact factor: 5.922

7.  Circadian clock-coordinated hepatic lipid metabolism: only transcriptional regulation?

Authors:  Frédéric Gachon; Xavier Bonnefont
Journal:  Aging (Albany NY)       Date:  2010-03-20       Impact factor: 5.682

Review 8.  The many intersecting pathways underlying apolipoprotein B secretion and degradation.

Authors:  Jeffrey L Brodsky; Edward A Fisher
Journal:  Trends Endocrinol Metab       Date:  2008-08-06       Impact factor: 12.015

9.  A novel combination treatment for breast cancer cells involving BAPTA-AM and proteasome inhibitor bortezomib.

Authors:  Azmi Yerlikaya; Elif Erdoğan; Emrah Okur; Şerife Yerlikaya; Bircan Savran
Journal:  Oncol Lett       Date:  2016-05-17       Impact factor: 2.967

10.  Glucosamine-induced endoplasmic reticulum stress attenuates apolipoprotein B100 synthesis via PERK signaling.

Authors:  Wei Qiu; Qiaozhu Su; Angela C Rutledge; Jing Zhang; Khosrow Adeli
Journal:  J Lipid Res       Date:  2009-04-21       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.